Effects of Nintedanib in an Animal Model of Liver Fibrosis.

Biomed Res Int · 2020 · PMC7150695 · PMID 32337244

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a weak trendno p-value reported

Therapeutic Treatment Nintedanib treatment resulted in a weak trend towards reduced body weight (< 5% at 60 mg/kg/day) compared with control or CCL 4 -only treated animals from both days 7 and 14 (data not shown).

also in 1,404 other papers

a nonsignificant trendno p-value reported

There was a nonsignificant trend towards dose-dependent reduction in AST ( Figure 6(d) ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.